138 related articles for article (PubMed ID: 34850779)
1. Roles of hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha, a lipid metabolism enzyme, in Wilms tumor patients.
Wu X; Feng R; Wang X; Guo F; Liu W
J Cancer Res Ther; 2021 Nov; 17(5):1281-1285. PubMed ID: 34850779
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.
Zhao Z; Lu J; Han L; Wang X; Man Q; Liu S
Tumour Biol; 2016 Jun; 37(6):8121-30. PubMed ID: 26715271
[TBL] [Abstract][Full Text] [Related]
3. HADHA overexpression disrupts lipid metabolism and inhibits tumor growth in clear cell renal cell carcinoma.
Liu S; Liu X; Wu F; Zhang X; Zhang H; Gao D; Bi D; Qu H; Ge J; Xu Y; Zhao Z
Exp Cell Res; 2019 Nov; 384(1):111558. PubMed ID: 31472118
[TBL] [Abstract][Full Text] [Related]
4. Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor.
Wang X; Du G; Wu Y; Zhang Y; Guo F; Liu W; Wu R
Int J Oncol; 2020 Feb; 56(2):568-580. PubMed ID: 31894270
[TBL] [Abstract][Full Text] [Related]
5. Analysis of a family with mitochondrial trifunctional protein deficiency caused by
Yang J; Yuan D; Tan X; Zeng Y; Tang N; Chen D; Tan J; Cai R; Huang J; Yan T
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34878152
[TBL] [Abstract][Full Text] [Related]
6. The protein acetylase GCN5L1 modulates hepatic fatty acid oxidation activity via acetylation of the mitochondrial β-oxidation enzyme HADHA.
Thapa D; Wu K; Stoner MW; Xie B; Zhang M; Manning JR; Lu Z; Li JH; Chen Y; Gucek M; Playford MP; Mehta NN; Harmon D; O'Doherty RM; Jurczak MJ; Sack MN; Scott I
J Biol Chem; 2018 Nov; 293(46):17676-17684. PubMed ID: 30323061
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological parameters and prognostic relevance of miR-21 and PTEN expression in Wilms' tumor.
Cui M; Liu W; Zhang L; Guo F; Liu Y; Chen F; Liu T; Ma R; Wu R
J Pediatr Surg; 2017 Aug; 52(8):1348-1354. PubMed ID: 28040201
[TBL] [Abstract][Full Text] [Related]
8. MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming.
Liu Y; Lu LL; Wen D; Liu DL; Dong LL; Gao DM; Bian XY; Zhou J; Fan J; Wu WZ
J Hematol Oncol; 2020 Feb; 13(1):12. PubMed ID: 32033570
[TBL] [Abstract][Full Text] [Related]
9. Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.
Qi C; Hu Y; Yang F; An H; Zhang J; Jin H; Guo F
J Pediatr Surg; 2016 Sep; 51(9):1501-6. PubMed ID: 27230801
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization mapping of the alpha and beta subunits (HADHA and HADHB) of human mitochondrial fatty acid beta-oxidation multienzyme complex to 2p23 and their evolution.
Aoyama T; Wakui K; Orii KE; Hashimoto T; Fukushima Y
Cytogenet Cell Genet; 1997; 79(3-4):221-4. PubMed ID: 9605857
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma.
Yamamoto K; Abe S; Honda A; Hashimoto J; Aizawa Y; Ishibashi S; Takemura T; Hanagata N; Yamamoto M; Miura O; Kurata M; Kitagawa M
Lab Invest; 2020 Mar; 100(3):353-362. PubMed ID: 31527828
[TBL] [Abstract][Full Text] [Related]
12. Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor.
Diniz G; Aktas S; Turedi A; Temir G; Ortac R; Vergin C
Tumour Biol; 2011 Aug; 32(4):761-7. PubMed ID: 21553236
[TBL] [Abstract][Full Text] [Related]
13. Evidence for clonal development of Wilms' tumor.
Wilimas JA; Dow LW; Douglass EC; Jenkins JJ; Jacobson RJ; Moohr J; Fialkow PJ
Am J Pediatr Hematol Oncol; 1991; 13(1):26-8. PubMed ID: 1851399
[TBL] [Abstract][Full Text] [Related]
14. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive HADHA c.1528G>C frequency study reveals high prevalence of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency in Poland.
Piekutowska-Abramczuk D; Olsen RK; Wierzba J; Popowska E; Jurkiewicz D; Ciara E; Ołtarzewski M; Gradowska W; Sykut-Cegielska J; Krajewska-Walasek M; Andresen BS; Gregersen N; Pronicka E
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S373-7. PubMed ID: 20814823
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular investigation of 14 Japanese patients with complete TFP deficiency: a comparison with Caucasian cases.
Bo R; Yamada K; Kobayashi H; Jamiyan P; Hasegawa Y; Taketani T; Fukuda S; Hata I; Niida Y; Shigematsu Y; Iijima K; Yamaguchi S
J Hum Genet; 2017 Sep; 62(9):809-814. PubMed ID: 28515471
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.
Ghanem MA; Van Der Kwast TH; Den Hollander JC; Sudaryo MK; Mathoera RB; Van den Heuvel MM; Noordzij MA; Nijman RJ; van Steenbrugge GJ
Cancer; 2001 Dec; 92(12):3120-9. PubMed ID: 11753991
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte elevated gene-1 overexpression in histologically favorable Wilms tumor is related to poor prognosis.
Guo F; Zhang LJ; Liu W; Wang G; Liu HY; Wang YL; Ma R; Wu RD
J Pediatr Urol; 2014 Apr; 10(2):317-23. PubMed ID: 24119914
[TBL] [Abstract][Full Text] [Related]
19. Using Elevated Cholesterol Synthesis as a Prognostic Marker in Wilms' Tumor: A Bioinformatic Analysis.
He Y; Cui X; Lin Y; Wang Y; Wu D; Fang Y
Biomed Res Int; 2021; 2021():8826286. PubMed ID: 33628817
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
